Document is current
Any future updates will be listed below
-
Authors
Rashid, Narmeen S.
Lamba, Nayan
Catalano, Paul J.
Elhalawani, Hesham
Tanguturi, Shyam K.
Rahman, Rifaquat
Haas-Kogan, Daphne A.
Wen, Patrick Y.
Aizer, Ayal A.
-
Funding
Funding for this research was provided by:
Office of Scholarly Engagement, Program in Medical Education, Harvard Medical School
Dana-Farber Cancer Institute Pan Mass Challenge Team Janet’s Mafia
Best Fitness Gyms
- License Information
-
More Information
Article History
Received: 4 February 2025
Accepted: 22 March 2025
First Online: 15 April 2025
Declarations
:
: This study was approved by the Dana-Farber/Harvard Cancer Center Institutional Review Board. Informed consent was waived.
: A waiver of informed consent was obtained.
: A waiver of informed consent was obtained.
: RR reports advisory board/consulting activities for Servier Pharmaceuticals, Telix Pharmaceuticals, St. Lucia Consulting, and NH TherAguix. PYW reports research support from Astra Zeneca, Black Diamond, Bristol Meyers Squibb, Chimerix, Eli Lily, Erasca, Global Coalition For Adaptive Research, Kazia, MediciNova, Merck, Novartis, Quadriga, Servier, and VBI Vaccines and advisory board/consulting activities for Anheart, Astra Zeneca, Black Diamond, Celularity, Chimerix, Day One Bio, Genenta, Glaxo Smith Kline, Kintara, Merck, Mundipharma, Novartis, Novocure, Prelude Therapeutics, Sagimet, Sapience, Servier, Symbio, Tango, Telix, VBI Vaccines. AAA reports research funding from Varian and NH TheraAguix and consulting for Novartis and Seagen. No other disclosures were reported.
